BSE: METROPOLIS - Metropolis Healthcare Limited

Rentabilität für sechs Monate: -24.95%
Dividendenrendite: 0.00%
Sektor: Healthcare

Aktionsplan Metropolis Healthcare Limited


Über das Unternehmen Metropolis Healthcare Limited

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services.

weitere details
As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

ISIN INE112L01020
Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.7235
Дивиденд ао 4
Сайт https://www.metropolisindia.com
Цена ао 1658.55
Preisänderung pro Tag: -3.34% (1641.55)
Preisänderung pro Woche: -4.05% (1653.7)
Preisänderung pro Monat: -11.42% (1791.25)
Preisänderung über 3 Monate: -25.93% (2142.3)
Preisänderung über sechs Monate: -24.95% (2114.3)
Preisänderung pro Jahr: -0.955% (1602.05)
Preisänderung über 3 Jahre: -21.88% (2031.1)
Preisänderung über 5 Jahre: -2.59% (1629)
Preisänderung über 10 Jahre: 0% (1586.75)
Preisänderung seit Jahresbeginn: -27.03% (2174.6)

Unterschätzung

Name Bedeutung Grad
P/S 6.8 1
P/BV 7.47 1
P/E 64.26 1
EV/EBITDA 20.82 5
Gesamt: 3.38

Effizienz

Name Bedeutung Grad
ROA, % 8.36 3
ROE, % 12.26 4
Gesamt: 5

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0.75 7.5
Gesamt: 1.85

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0.2605 10
Gesamt: 9.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 41.11 6
Rentabilität Ebitda, % 40.29 6
Rentabilität EPS, % -1.31 0
Gesamt: 3



Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Dr. Sushil Kanubhai Shah Founder & Chairman Emeritus 18M 1946 (79 Jahre)
Mr. Surendran Chemmenkotil Chief Executive Officer 52.32M
Mr. Rakesh Kumar Agarwal Chief Financial Officer 13.83M
Ms. Ameera Sushil Shah Executive Chairperson 52.4M 1979 (46 Jahre)
Mr. Kannan Alangadan Chief Operating Officer N/A
Dr. Kirti Chadha Chief Scientific & Innovation Officer N/A

Adresse: India, Mumbai, East Wing Plot-254 B Nirlon House - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.metropolisindia.com